Table 1 A list of disease-modifying antirheumatic drugs included in the study
From: Validation of rheumatoid arthritis diagnoses in health care utilization data
Abatacept |
Adalimumab |
Anakinra |
Azathioprine |
Cyclosporin |
D-penicillamine |
Etanercept |
Gold |
Hydroxychloroquine |
Infliximab |
Leflunomide |
Methotrexate |
Minocycline |
Rituximab |
Sulfasalazine |